Skip to main content
Top
Published in: Journal of Clinical Immunology 3/2014

01-04-2014 | Original Research

Altered miRNAs Expression Profiles and Modulation of Immune Response Genes and Proteins During Neonatal Sepsis

Authors: Jiande Chen, Siyuan Jiang, Yun Cao, Yi Yang

Published in: Journal of Clinical Immunology | Issue 3/2014

Login to get access

Abstract

Purpose

The dysregulated expression of miRNAs in the immune system may be critical for immune responses to pathogens and evolve into the inflammation seen in sepsis. The aim of this study is to explore the important role of miRNAs in the regulation of the immune response during neonatal sepsis.

Methods

Using a microarray we performed the miRNA expression profiling of peripheral blood leukocytes from neonates with sepsis and uninfected neonates. Based on the predicted target genes of these miRNAs we selected 26 immune-related miRNAs out of the differentially expressed miRNAs for further testing by quantitative PCR. We simultaneously detected the immune response genes by PCR array and plasma cytokine levels using a protein chip to investigate the effect of the altered miRNAs on the immune response in neonatal sepsis.

Results

There were 10 immune regulatory miRNAs whose expression was significantly changed more than two fold in the neonates with sepsis compared with the uninfected neonates. The expression levels of 11 immune response genes and the plasma levels of 15 cytokines or receptors were significantly up- or down-regulated in the neonates with sepsis compared to the uninfected neonates. This comprehensive analysis suggests that the altered miRNAs modulate the immune response during neonatal sepsis in a way that represses the inflammatory response.

Conclusions

Our investigation demonstrated some miRNAs with altered expression levels and their probable association with the regulation of immune response during neonatal sepsis. The characteristics of the neonatal inflammatory response could be attributed to immature immune function of neonates.
Literature
1.
go back to reference Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin N Am. 2013;60:367–89.CrossRef Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin N Am. 2013;60:367–89.CrossRef
2.
go back to reference Thaver D, Zaidi AK. Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatr Infect Dis J. 2009;28(1 Suppl):S3–9.PubMedCrossRef Thaver D, Zaidi AK. Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatr Infect Dis J. 2009;28(1 Suppl):S3–9.PubMedCrossRef
4.
go back to reference Futata EA, Fusaro AE, de Brito CA, Sato MN. The neonatal immune system immunomodulation of infections in early life. Expert Rev Anti Infect Ther. 2012;10:289–98.PubMedCrossRef Futata EA, Fusaro AE, de Brito CA, Sato MN. The neonatal immune system immunomodulation of infections in early life. Expert Rev Anti Infect Ther. 2012;10:289–98.PubMedCrossRef
6.
go back to reference Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell. 2009;136:26–36.PubMedCrossRef Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell. 2009;136:26–36.PubMedCrossRef
9.
go back to reference Liston A, Linterman M, Lu LF. MicroRNA in the adaptive immune system, in sickness and in health. J Clin Immunol. 2010;30:339–46.PubMedCrossRef Liston A, Linterman M, Lu LF. MicroRNA in the adaptive immune system, in sickness and in health. J Clin Immunol. 2010;30:339–46.PubMedCrossRef
10.
go back to reference Wang HJ, Zhang PJ, Chen WJ, Jie D, Dan F, Jia YH, et al. Characterization and identification of novel serum microRNAs in sepsis patients with different outcomes. Shock. 2013;39:480–7.PubMedCrossRef Wang HJ, Zhang PJ, Chen WJ, Jie D, Dan F, Jia YH, et al. Characterization and identification of novel serum microRNAs in sepsis patients with different outcomes. Shock. 2013;39:480–7.PubMedCrossRef
11.
go back to reference Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie L. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients’ mortality: a prospective observational study. PLoS One. 2012;7:e38885.PubMedCentralPubMedCrossRef Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie L. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients’ mortality: a prospective observational study. PLoS One. 2012;7:e38885.PubMedCentralPubMedCrossRef
12.
go back to reference Wang HJ, Zhang PJ, Chen WJ, Feng D, Jia YH, Xie LX. Four serum microRNAs identified as diagnostic biomarkers of sepsis. J Trauma Acute Care Surg. 2012;73:850–4.PubMedCrossRef Wang HJ, Zhang PJ, Chen WJ, Feng D, Jia YH, Xie LX. Four serum microRNAs identified as diagnostic biomarkers of sepsis. J Trauma Acute Care Surg. 2012;73:850–4.PubMedCrossRef
13.
go back to reference Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie LX. Evidence for serum miR-15a and miR-16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects. Clin Chem Lab Med. 2012;50:1423–8.PubMed Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie LX. Evidence for serum miR-15a and miR-16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects. Clin Chem Lab Med. 2012;50:1423–8.PubMed
14.
go back to reference Wang JF, Yu ML, Yu G, Bian JJ, Deng XM, Wan XJ, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun. 2010;394:184–8.PubMedCrossRef Wang JF, Yu ML, Yu G, Bian JJ, Deng XM, Wan XJ, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun. 2010;394:184–8.PubMedCrossRef
15.
go back to reference Schmidt WM, Spiel AO, Jilma B, Wolzt M, Müller M. In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun. 2009;380:437–41.PubMedCrossRef Schmidt WM, Spiel AO, Jilma B, Wolzt M, Müller M. In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem Biophys Res Commun. 2009;380:437–41.PubMedCrossRef
16.
go back to reference Subspecialty Group of Neonatology Pediatric Society Chinese Medical Association; Editorial Board Chinese Journal of Pediatrics. [Protocol for diagnosis and treatment of neonatal septicemia]. Zhonghua Er Ke Za Zhi. 2003;41:897–9. Subspecialty Group of Neonatology Pediatric Society Chinese Medical Association; Editorial Board Chinese Journal of Pediatrics. [Protocol for diagnosis and treatment of neonatal septicemia]. Zhonghua Er Ke Za Zhi. 2003;41:897–9.
17.
go back to reference Skirecki T, Borkowska-Zielińska U, Złotorowicz M, Hoser G. Sepsis immunopathology: perspectives of monitoring and modulation of the immune disturbances. Arch Immunol Ther Exp (Warsz). 2012;60:123–35.CrossRef Skirecki T, Borkowska-Zielińska U, Złotorowicz M, Hoser G. Sepsis immunopathology: perspectives of monitoring and modulation of the immune disturbances. Arch Immunol Ther Exp (Warsz). 2012;60:123–35.CrossRef
18.
21.
go back to reference Wynn JL, Neu J, Moldawer LL, Levy O. Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J Perinatol. 2009;29:79–88.PubMedCrossRefPubMedCentral Wynn JL, Neu J, Moldawer LL, Levy O. Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J Perinatol. 2009;29:79–88.PubMedCrossRefPubMedCentral
22.
23.
go back to reference Gantier MP. New perspectives in MicroRNA regulation of innate immunity. J Interferon Cytokine Res. 2010;30(2):83–9. Gantier MP. New perspectives in MicroRNA regulation of innate immunity. J Interferon Cytokine Res. 2010;30(2):83–9.
24.
go back to reference Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One. 2009;4:e7405.PubMedCentralPubMedCrossRef Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One. 2009;4:e7405.PubMedCentralPubMedCrossRef
25.
go back to reference Ishihara K, Sasaki D, Tsuruda K, Inokuchi N, Nagai K, Hasegawa H, et al. Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia. Cancer Epidemiol. 2012;36:560–5.PubMedCrossRef Ishihara K, Sasaki D, Tsuruda K, Inokuchi N, Nagai K, Hasegawa H, et al. Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia. Cancer Epidemiol. 2012;36:560–5.PubMedCrossRef
27.
go back to reference Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;7:379–90.PubMedCrossRef Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;7:379–90.PubMedCrossRef
28.
go back to reference Kollmann TR, Levy O, Montgomery RR, Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity. 2012;37:771–83.PubMedCentralPubMedCrossRef Kollmann TR, Levy O, Montgomery RR, Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity. 2012;37:771–83.PubMedCentralPubMedCrossRef
29.
go back to reference Ygberg S, Nilsson A. The developing immune system - from foetus to toddler. Acta Paediatr. 2012;101:120–7.PubMedCrossRef Ygberg S, Nilsson A. The developing immune system - from foetus to toddler. Acta Paediatr. 2012;101:120–7.PubMedCrossRef
30.
go back to reference Caldas JP, Marba ST, Blotta MH, Calil R, Morais SS, Oliveira RT. Accuracy of white blood cell count, C-reactive protein, interleukin-6 and tumor necrosis factor alpha for diagnosing late neonatal sepsis. J Pediatr (Rio J). 2008;84:536–42.CrossRef Caldas JP, Marba ST, Blotta MH, Calil R, Morais SS, Oliveira RT. Accuracy of white blood cell count, C-reactive protein, interleukin-6 and tumor necrosis factor alpha for diagnosing late neonatal sepsis. J Pediatr (Rio J). 2008;84:536–42.CrossRef
31.
go back to reference Sherwin C, Broadbent R, Young S, Worth J, McCaffrey F, Medlicott NJ, et al. Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis. Am J Perinatol. 2008;25:629–36.PubMedCrossRef Sherwin C, Broadbent R, Young S, Worth J, McCaffrey F, Medlicott NJ, et al. Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis. Am J Perinatol. 2008;25:629–36.PubMedCrossRef
32.
go back to reference Hodge G, Hodge S, Haslam R, McPhee A, Sepulveda H, Morgan E, et al. Rapid simultaneous measurement of multiple cytokines using 100 microl sample volumes–association with neonatal sepsis. Clin Exp Immunol. 2004;137:402–7.PubMedCentralPubMedCrossRef Hodge G, Hodge S, Haslam R, McPhee A, Sepulveda H, Morgan E, et al. Rapid simultaneous measurement of multiple cytokines using 100 microl sample volumes–association with neonatal sepsis. Clin Exp Immunol. 2004;137:402–7.PubMedCentralPubMedCrossRef
33.
go back to reference Protonotariou E, Malamitsi-Puchner A, Rizos D, Sarandakou A, Makrakis E, Salamolekis E. Alterations in Thl/Th2 cytokine concentrations in early neonatal life. J Matern Fetal Neonatal Med. 2003;14:407–10.PubMedCrossRef Protonotariou E, Malamitsi-Puchner A, Rizos D, Sarandakou A, Makrakis E, Salamolekis E. Alterations in Thl/Th2 cytokine concentrations in early neonatal life. J Matern Fetal Neonatal Med. 2003;14:407–10.PubMedCrossRef
34.
go back to reference Cabal-Hierro L, Lazo PS. Signal transduction by tumor necrosis factor receptors. Cell Signal. 2012;24:1297–305.PubMedCrossRef Cabal-Hierro L, Lazo PS. Signal transduction by tumor necrosis factor receptors. Cell Signal. 2012;24:1297–305.PubMedCrossRef
35.
36.
go back to reference Harper KA, Tyson-Capper AJ. Complexity of COX-2 gene regulation. Biochem Soc Trans. 2008;36:543–5.PubMedCrossRef Harper KA, Tyson-Capper AJ. Complexity of COX-2 gene regulation. Biochem Soc Trans. 2008;36:543–5.PubMedCrossRef
37.
go back to reference Pham H, Ekaterina Rodriguez C, Donald GW, Hertzer KM, Jung XS, Chang HH, et al. miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells. Biochem Biophys Res Commun. 2013;439:6–11.PubMedCrossRef Pham H, Ekaterina Rodriguez C, Donald GW, Hertzer KM, Jung XS, Chang HH, et al. miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells. Biochem Biophys Res Commun. 2013;439:6–11.PubMedCrossRef
38.
go back to reference O’Connell RM, Rao DS Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol. 2012;30:295–312.PubMedCrossRef O’Connell RM, Rao DS Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol. 2012;30:295–312.PubMedCrossRef
39.
go back to reference Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007;129:147–61.PubMedCrossRef Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007;129:147–61.PubMedCrossRef
40.
go back to reference Stittrich AB, Haftmann C, Sgouroudis E, Kühl AA, Hegazy AN, Panse I, et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol. 2010;11:1057–62.PubMedCrossRef Stittrich AB, Haftmann C, Sgouroudis E, Kühl AA, Hegazy AN, Panse I, et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol. 2010;11:1057–62.PubMedCrossRef
41.
go back to reference Ma F, Xu S, Liu X, Zhang Q, Xu X, Liu M, et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat Immunol. 2011;12:861–9.PubMedCrossRef Ma F, Xu S, Liu X, Zhang Q, Xu X, Liu M, et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat Immunol. 2011;12:861–9.PubMedCrossRef
42.
go back to reference Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest. 2012;122:2871–83.PubMedCentralPubMedCrossRef Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest. 2012;122:2871–83.PubMedCentralPubMedCrossRef
43.
go back to reference Gatsiou A, Boeckel JN, Randriamboavonjy V, Stellos K. MicroRNAs in platelet biogenesis and function: implications in vascular homeostasis and inflammation. Curr Vasc Pharmacol. 2012;10:524–31.PubMedCrossRef Gatsiou A, Boeckel JN, Randriamboavonjy V, Stellos K. MicroRNAs in platelet biogenesis and function: implications in vascular homeostasis and inflammation. Curr Vasc Pharmacol. 2012;10:524–31.PubMedCrossRef
44.
go back to reference Zhu QY, Liu Q, Chen JX, Lan K, Ge BX. MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J Immunol. 2010;185:7435–42.PubMedCrossRef Zhu QY, Liu Q, Chen JX, Lan K, Ge BX. MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J Immunol. 2010;185:7435–42.PubMedCrossRef
Metadata
Title
Altered miRNAs Expression Profiles and Modulation of Immune Response Genes and Proteins During Neonatal Sepsis
Authors
Jiande Chen
Siyuan Jiang
Yun Cao
Yi Yang
Publication date
01-04-2014
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 3/2014
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-014-0004-9

Other articles of this Issue 3/2014

Journal of Clinical Immunology 3/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.